First Clinically Approved Immunotherapy for Cancer Treatment
SUMMARY OF CLINICAL TRIALS
Body Revival, Health Reactive is the first ayurvedic product in the world to conduct clinical trials on cancer patients.
The clinical trials were conducted following the details of CTRI -ICMR.
These trials, officially registered with the Clinical Trials Registry of India (CTRI-ICMR), under CTRI/2023/11/059465. The clinical trial highlighted:
- Enhanced Quality of Life (QoL): Body Revival® significantly improved physical and psychological well-being in breast cancer patients.
- Improved Performance Status: Patients reported enhanced daily functionality and energy levels.
- Reduction in Side Effects: Patients experienced fewer chemotherapy and radiation-related side effects.
- Enhanced Physical Health: Increased appetite, stamina, and endurance, coupled with reductions in nausea, constipation, muscle weakness, dizziness, and fatigue.
- Liver and Blood Benefits: Marked decreased liver enzyme levels and improved blood protein and haemoglobin counts.
